NTIDs # HVDs (or not?) [Design Issues]

posted by Dr_Dan  – Germany, 2010-06-08 14:24 (5864 d 02:05 ago) – Posting: # 5468
Views: 10,733

Hi Helmut

❝ If we are talking about immunosuppressants, we are talking about a study in patients, right? Steady state too. Likely parallel design – it’s unethical to interrupt treatment by a washout.


If you investigate steady state PK you can do an "active washout" without interrupting treatment.

Regards
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
356 visitors (0 registered, 356 guests [including 18 identified bots]).
Forum time: 16:29 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5